Prostate Cancer Treatment at Massachusetts General Hospital
Prostate Cancer Treatment at Massachusetts General Hospital provides specialist evaluation and individualized treatment planning for men diagnosed with prostate cancer. Treatment decisions may depend on the stage and grade of the cancer, tumor characteristics, overall health, age, previous treatment, and personal preferences.
Massachusetts General Hospital provides multidisciplinary cancer and urological care, allowing patients to receive coordinated assessment involving urology, oncology, radiation specialists, imaging, pathology, and other relevant medical services when appropriate.
Price on Request
The cost of prostate cancer treatment may vary depending on the cancer stage, diagnostic requirements, treatment approach, surgery or radiation needs, medications, specialist consultations, hospital services, and follow-up care. A personalized cost estimate can be provided after reviewing the patient's medical records and determining the appropriate treatment plan.
Prostate cancer treatment refers to medical and surgical approaches used to manage cancer originating in the prostate gland.
Treatment may involve active surveillance, surgery, radiation therapy, hormone-based treatment, systemic therapy, or combinations of different approaches depending on the patient's diagnosis and clinical circumstances.
Prostate cancer treatment may be considered for men with:
Newly diagnosed prostate cancer
Localized prostate cancer
Locally advanced prostate cancer
Recurrent prostate cancer
Advanced or metastatic prostate cancer
Rising prostate-specific antigen levels after previous treatment
Abnormal prostate biopsy findings
Cancer requiring a specialist second opinion
The most appropriate treatment depends on the individual's cancer characteristics and overall health.
Accurate diagnosis and staging are important for determining an appropriate treatment strategy.
The medical team may review prostate biopsy findings, PSA results, imaging studies, physical examination findings, and other clinical information to determine the extent and characteristics of the cancer.
Pathology results from prostate biopsy may provide important information about the type and grade of cancer.
Specialist review of pathology findings may help the medical team assess disease characteristics and consider appropriate treatment options.
Prostate-specific antigen testing may be used as part of prostate cancer diagnosis, monitoring, and follow-up.
PSA levels may be considered together with biopsy results, imaging, treatment history, and other clinical information rather than being evaluated in isolation.
Imaging may be used to evaluate the prostate and determine whether cancer may have extended beyond the prostate.
Depending on the clinical situation, imaging may include MRI, CT, bone imaging, PET-based studies, or other appropriate examinations.
For selected patients with lower-risk prostate cancer, active surveillance may be considered instead of immediate treatment.
This approach involves regular monitoring through appropriate examinations, PSA testing, imaging, and repeat assessment when indicated.
Surgical removal of the prostate may be considered for selected patients with localized or certain locally advanced prostate cancer.
The suitability of surgery depends on the patient's cancer characteristics, overall health, previous treatment, and clinical assessment.
Radiation therapy may be used to treat prostate cancer in appropriate patients.
Treatment may involve external radiation or other radiation-based approaches depending on the cancer characteristics and individualized treatment plan.
Hormonal therapy may be used when prostate cancer is sensitive to androgen-related growth signals.
It may be recommended alone or in combination with other treatments depending on the stage, risk profile, recurrence pattern, and overall treatment strategy.
Patients with prostate cancer that has spread beyond the prostate may require systemic treatment and multidisciplinary care.
Treatment options may include hormone-based therapy, chemotherapy, targeted treatment, radiopharmaceutical approaches, or other therapies when clinically appropriate.
Cancer may recur after initial treatment in some patients. Evaluation of recurrent disease may involve PSA monitoring, imaging, pathology review, and assessment of previous treatment.
Further management is determined according to the location and extent of recurrence and the patient's overall clinical condition.
Prostate cancer treatment may involve several medical specialties.
Depending on the patient's condition, care may include urologic oncology, medical oncology, radiation oncology, radiology, pathology, nuclear medicine, and other relevant specialists.
There is no single treatment approach suitable for every prostate cancer patient.
The medical team may consider cancer stage, grade, PSA level, imaging findings, age, general health, previous treatments, and patient preferences when developing an individualized treatment plan.
Patients receiving prostate cancer treatment may require ongoing monitoring.
Follow-up can include PSA testing, clinical assessment, imaging, medication review, and evaluation of treatment-related effects according to the patient's treatment plan.
Prostate cancer treatment can be associated with potential effects involving urinary function, sexual health, bowel function, hormonal changes, and general well-being.
The healthcare team may monitor these concerns and provide appropriate management or referral when required.
Patients diagnosed with prostate cancer may seek a specialist second opinion regarding diagnosis, cancer staging, treatment options, surgery, radiation, or systemic therapy.
Review of pathology, imaging, PSA results, and previous treatment records can help provide a comprehensive assessment.
Patients seeking prostate cancer treatment should provide relevant medical records when available.
These may include prostate biopsy and pathology reports, PSA results, MRI or other imaging studies, previous treatment records, medication lists, and discharge summaries.
International patients seeking prostate cancer treatment may be required to provide medical records, pathology reports, imaging studies, PSA results, medication information, and previous treatment history for review.
International patient services are subject to applicable eligibility, referral, appointment, and hospital requirements.
Potential benefits of specialist prostate cancer care include:
Comprehensive assessment of prostate cancer
Review of cancer stage and grade
Specialist pathology and imaging review
Individualized treatment planning
Access to surgical treatment when appropriate
Evaluation of radiation-based treatment options
Assessment of systemic and hormone-based therapies
Multidisciplinary cancer care
Long-term treatment monitoring and follow-up
Massachusetts General Hospital provides specialist cancer and urological care within a major academic medical environment. Patients with prostate cancer may benefit from multidisciplinary assessment and coordination between urology, oncology, radiation therapy, pathology, and diagnostic services.
For patients with complex or advanced prostate cancer, coordinated specialist care can support individualized treatment planning based on the patient's specific clinical circumstances.
The overall cost depends on the cancer stage, diagnostic testing, treatment approach, surgery or radiation requirements, medications, specialist consultations, hospital services, and follow-up care.
Because treatment requirements vary significantly between patients, this service is offered at Price on Request following appropriate medical review.
Depending on the cancer stage and individual circumstances, treatment may include active surveillance, surgery, radiation therapy, hormone-based treatment, systemic therapy, or combinations of these approaches.
Staging may involve PSA testing, prostate biopsy and pathology review, physical examination, and appropriate imaging. The specific investigations depend on the patient's diagnosis and risk profile.
No. Some patients may be managed with active surveillance, radiation therapy, medication, or other approaches. Treatment depends on the cancer's characteristics and the patient's overall clinical situation.
Yes. A specialist second opinion can help review the diagnosis, pathology, imaging, staging, and proposed treatment plan and may provide additional perspective on available management options.
International patients may be considered subject to applicable eligibility, referral, appointment, and hospital requirements. Medical records and diagnostic reports may need to be reviewed before treatment planning.
Product Name: Prostate Cancer Treatment at Massachusetts General Hospital
Hospital: Massachusetts General Hospital
Brand: Massachusetts General Hospital
Country: United States
Location: Boston, Massachusetts, USA
Specialty: Urology
Service Type: Prostate Cancer Treatment
Customer-Facing Price: Price on Request
International Patients: Subject to applicable eligibility and appointment requirements
Frequently Bought Together
Products from this Seller
View All
Subscribe our newsletter for coupon, offer and exciting promotional discount..
Share with Friends
Trading is more effective when you share products with friends!Share you link
Share to